QurAlis Corporation is a Cambridge (USA) based biotech company focused on developing precision therapeutics for ALS and other neurological diseases.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
11/19/18 | $5,500,000 | Seed |
Amgen Business Development MP Healthcare Venture Management Viva Biotech | undisclosed |
05/13/20 | $42,000,000 | Series A |
Amgen Business Development Dementia Discovery Fund ![]() Dolby Family Ventures DROIA Oncology Ventures ![]() INKEF Capital ![]() LS Polaris Innovation Fund ![]() Mission BioCapital ![]() Mitsui Global Investment MP Healthcare Venture Management Sanford Biosciences | undisclosed |
03/10/23 | $88,000,000 | Series B |
ALS Investment Fund Amgen Ventures Dementia Discovery Fund Dolby Family Ventures DROIA Ventures EQT Life Sciences ![]() INKEF Capital LS Polaris Innovation Fund Mission Bay Capital Mission BioCapital Mitsui Global Investment MP Healthcare Venture Management Sanford Biosciences Sanofi Ventures | undisclosed |